Halmos enables biotech teams to get more out of every experiment. It reads the literature, runs simulations, and selects or trains models to optimize every step — so you extract more information across discovery, process development, scale-up, and manufacturing.
https://youtu.be/u1ptzxsgzWo
The problem
Experiments are slow, expensive, and most of the information they could yield is wasted. Teams run tedious trial-and-error or exhaustive screens, burning months of lab time and budget to reach conclusions better experimental design would have reached far sooner. The pharmaceutical industry alone performed $126B of U.S. R&D in 2023.
How it works
Halmos runs unbounded research by coordinating hundreds of AI agents, checks the logical consistency of their reasoning, and revisits arguments that fail validation before presenting conclusions to your team.
Zero installations, no data engineering, and no need for your own statistics team.
Tested in industry:
Towards increasingly large R&D tasks
We start by designing experiments. From there we take on increasingly large R&D tasks until we can run full end-to-end programs for biotech teams at a fraction of the cost of a consultant — enabling new discoveries in less well funded industries like food, rare diseases, biomaterials, and agriculture.
Team
Our ask
If you run biotech R&D, process development, assay development, or manufacturing optimization, we want to hear from you. Scope an experiment with us at halmoslabs.com or email hi@halmoslabs.com (enterprise inquiries welcome).